Story perspectives

Experts Warn on MFN Pricing Risks Amid Manufacturer Withdrawal

11/5/2025

41 9

Summary

Story summary

U.S. President Donald Trump’s Most Favored Nation (MFN) executive order was discussed in a webinar, outlining pricing implications.
Experts urged manufacturers to collaborate on MFN pricing, with tariffs posing a risk to costs.
John Brooks of the Centers for Medicare & Medicaid Services noted the administration’s pressure on foreign nations to raise prices.
A major manufacturer withdrew from the Medicaid Drug Rebate Program, raising questions about future participation.

1 of 1

Story summary

U.S. President Donald Trump’s Most Favored Nation (MFN) executive order was discussed in a webinar, outlining pricing implications.
Experts urged manufacturers to collaborate on MFN pricing, with tariffs posing a risk to costs.
John Brooks of the Centers for Medicare & Medicaid Services noted the administration’s pressure on foreign nations to raise prices.
A major manufacturer withdrew from the Medicaid Drug Rebate Program, raising questions about future participation.